Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the role of a well-known and well-tolerated
antibiotic, doxycycline, in the treatment of cystic fibrosis patients who are hospitalized.
This antibiotic does not effectively treat the bacteria in airways of cystic fibrosis
patients, but may reduce the activity of inflammatory molecules in the disease.
Phase:
N/A
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborators:
Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics